These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 20850959

  • 21. Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population.
    To Y, Kinoshita M, Lee SH, Hang LW, Ichinose M, Fukuchi Y, Kitawaki T, Okino N, Prasad N, Lawrence D, Kramer B.
    Respir Med; 2012 Dec; 106(12):1715-21. PubMed ID: 23040786
    [Abstract] [Full Text] [Related]

  • 22. Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD.
    Beeh KM, Wagner F, Khindri S, Drollmann AF.
    COPD; 2011 Oct; 8(5):340-5. PubMed ID: 21793716
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies.
    Gotfried MH, Kerwin EM, Lawrence D, Lassen C, Kramer B.
    COPD; 2012 Dec; 9(6):629-36. PubMed ID: 23020650
    [Abstract] [Full Text] [Related]

  • 24. Cardiovascular safety of QVA149, a combination of Indacaterol and NVA237, in COPD patients.
    Van de Maele B, Fabbri LM, Martin C, Horton R, Dolker M, Overend T.
    COPD; 2010 Dec; 7(6):418-27. PubMed ID: 21166630
    [Abstract] [Full Text] [Related]

  • 25. Bronchodilator efficacy of single doses of indacaterol in Japanese patients with COPD: A randomised, double-blind, placebo-controlled trial.
    Kato M, Makita H, Uemura K, Fukuchi Y, Hosoe M, Emery C, Higgins M, Kramer B.
    Allergol Int; 2010 Sep; 59(3):285-293. PubMed ID: 20567133
    [Abstract] [Full Text] [Related]

  • 26. Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data.
    Bleecker ER, Siler T, Owen R, Kramer B.
    Int J Chron Obstruct Pulmon Dis; 2011 Sep; 6():431-8. PubMed ID: 22003288
    [Abstract] [Full Text] [Related]

  • 27. Chronic treatment with indacaterol and airway response to salbutamol in stable COPD.
    Cazzola M, Rogliani P, Ruggeri P, Segreti A, Proietto A, Picciolo S, Matera MG.
    Respir Med; 2013 Jun; 107(6):848-53. PubMed ID: 23490225
    [Abstract] [Full Text] [Related]

  • 28. Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD.
    Price D, Gray A, Gale R, Asukai Y, Mungapen L, Lloyd A, Peters L, Neidhardt K, Gantner T.
    Respir Med; 2011 Nov; 105(11):1635-47. PubMed ID: 21764277
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of indacaterol, a new 24-hour beta2-agonist, in patients with asthma: a dose-ranging study.
    Kanniess F, Boulet LP, Pierzchala W, Cameron R, Owen R, Higgins M.
    J Asthma; 2008 Dec; 45(10):887-92. PubMed ID: 19085578
    [Abstract] [Full Text] [Related]

  • 30. 24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol.
    Bauwens O, Ninane V, Van de Maele B, Firth R, Dong F, Owen R, Higgins M.
    Curr Med Res Opin; 2009 Feb; 25(2):463-70. PubMed ID: 19192991
    [Abstract] [Full Text] [Related]

  • 31. Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study.
    Korn S, Kerwin E, Atis S, Amos C, Owen R, Lassen C, INSIST study group.
    Respir Med; 2011 May; 105(5):719-26. PubMed ID: 21367594
    [Abstract] [Full Text] [Related]

  • 32. Indacaterol therapy in patients with COPD not receiving other maintenance treatment.
    Decramer M, Rossi A, Lawrence D, McBryan D.
    Respir Med; 2012 Dec; 106(12):1706-14. PubMed ID: 23031496
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study.
    Panettieri RA, MacIntyre N, Sims M, Kerwin E, Fogarty C, Noonan M, Claus R, Andrews WT.
    Clin Ther; 2009 Aug; 31(8):1716-23. PubMed ID: 19808130
    [Abstract] [Full Text] [Related]

  • 34. Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
    Jones PW, Mahler DA, Gale R, Owen R, Kramer B.
    Respir Med; 2011 Jun; 105(6):892-9. PubMed ID: 21397482
    [Abstract] [Full Text] [Related]

  • 35. Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.
    Rossi A, Centanni S, Cerveri I, Gulotta C, Foresi A, Cazzola M, Brusasco V.
    Respir Med; 2012 Jan; 106(1):84-90. PubMed ID: 22035851
    [Abstract] [Full Text] [Related]

  • 36. Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.
    Yang WH, Martinot JB, Pohunek P, Beier J, Magula D, Cameron R, Owen R, Higgins M.
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):555-61. PubMed ID: 18219838
    [Abstract] [Full Text] [Related]

  • 37. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
    Buhl R, Dunn LJ, Disdier C, Lassen C, Amos C, Henley M, Kramer B, INTENSITY study investigators.
    Eur Respir J; 2011 Oct; 38(4):797-803. PubMed ID: 21622587
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.
    Cope S, Capkun-Niggli G, Gale R, Lassen C, Owen R, Ouwens MJ, Bergman G, Jansen JP.
    Value Health; 2012 May; 15(3):524-33. PubMed ID: 22583463
    [Abstract] [Full Text] [Related]

  • 39. Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study.
    LaForce C, Alexander M, Deckelmann R, Fabbri LM, Aisanov Z, Cameron R, Owen R, Higgins M.
    Allergy; 2008 Jan; 63(1):103-11. PubMed ID: 18053019
    [Abstract] [Full Text] [Related]

  • 40. Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: a 26-week Asia-Pacific study.
    Yao W, Wang C, Zhong N, Han X, Wu C, Yan X, Chen P, Yang W, Henley M, Kramer B.
    Respirology; 2014 Feb; 19(2):231-238. PubMed ID: 24383720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.